About Ceftazidime 1000 + Tazobactam 125 Injection
Ceftazidime 1000mg + Tazobactam 125mg Injection is a sterile lyophilized powder for reconstitution, combining the third-generation cephalosporin ceftazidime with beta-lactamase inhibitor tazobactam in a 1.125g vial.
Ceftazidime disrupts bacterial cell wall synthesis by binding penicillin-binding proteins, while tazobactam inhibits resistance enzymes, enhancing efficacy against multi-drug resistant Gram-negative bacteria (including Pseudomonas aeruginosa), some Gram-positives, and anaerobes in serious infections.
Broad-Spectrum Defense Against InfectionsThis injection is crafted to target a wide array of challenging bacterial infections, including complicated intra-abdominal infections, ventilator-associated pneumonia, urinary tract infections, and septicemia. Its combination ensures heightened efficacy against both common and resistant bacteria.
Mechanism of Action: Dual ProtectionCeftazidime 1000 + Tazobactam 125 works by interrupting bacterial cell wall synthesis, essential for bacterial survival. Meanwhile, tazobactam acts by neutralizing beta-lactamase enzymes, allowing ceftazidime to remain active against resistant pathogens.
Convenient and Safe UsagePackaged in a single sterile vial, the powder is to be reconstituted for intravenous injection by medical professionals. The product maintains stability and efficacy for up to 24 months when stored in a cool, dry place, ensuring reliable use in clinical settings.
FAQ's of Ceftazidime 1000 + Tazobactam 125 Injection:
Q: How should Ceftazidime 1000 + Tazobactam 125 Injection be administered?
A: This injection is meant for intravenous use only and should be prepared and administered by qualified healthcare professionals. The sterile powder is reconstituted with a suitable diluent, then injected directly into a vein or through an IV line, following the prescribed dosage and guidelines.
Q: What infections does Ceftazidime 1000 + Tazobactam 125 Injection treat?
A: This antibiotic combination effectively treats complicated intra-abdominal infections, hospital-acquired and ventilator-associated pneumonia, complicated urinary tract infections (including pyelonephritis), skin and soft tissue infections, septicemia, gynecological infections, and bacterial meningitis caused by susceptible Gram-negative bacteria.
Q: When is it appropriate to use this injection instead of oral antibiotics?
A: Ceftazidime 1000 + Tazobactam 125 is reserved for severe or complicated infections where oral antibiotics are insufficient, such as hospital-acquired pneumonia, complicated UTIs, or systemic infections requiring rapid, potent intervention. It is typically used in inpatient settings under strict medical supervision.
Q: Where should Ceftazidime 1000 + Tazobactam 125 Injection be stored before use?
A: To preserve its potency, the vial should be stored in a cool, dry place, away from direct sunlight and moisture. The product maintains a shelf life of up to 24 months when kept under recommended storage conditions.
Q: What is the process for preparing the injection for administration?
A: The sterile powder contained in the vial must be reconstituted with an appropriate sterile diluent by a healthcare practitioner. After dissolving completely, the solution is administered intravenously, following strict aseptic technique and dosage instructions as provided by the doctor.
Q: What are the main benefits of using Ceftazidime 1000 + Tazobactam 125 Injection?
A: The key advantage of this formulation is its enhanced efficacy against resistant bacterial infections, due to the combination of ceftazidime's bactericidal activity and tazobactam's protective effect against beta-lactamases. This combination broadens the spectrum and reliability of treatment for serious hospital-related infections.